BioLineRX
BLRX
31 hedge funds and large institutions have $16.3M invested in BioLineRX in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.
3% more capital invested
Capital invested by funds: $15.7M → $16.3M (+$524K)
0.01% less ownership
Funds ownership: 0.05% → 0.04% (-0.01%)
9% less funds holding
Funds holding: 34 → 31 (-3)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
+$1.32M |
| 2 |
DG
Delek Group
Herzliya,
Israel
|
+$105K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$18.1K |
| 4 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
+$11.1K |
| 5 |
VF
Virtu Financial
New York
|
+$6.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$304K |
| 2 |
MC
Menta Capital
San Francisco,
California
|
-$33K |
| 3 |
Renaissance Technologies
New York
|
-$27K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$26K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Creative Planning
Overland Park,
Kansas
| $4K | – | – | – |
|
|
CAN
27
Cetera Advisor Networks
El Segundo,
California
| $4K | +$4.95K | +17 | New |
|
|
PVH
28
Psagot Value Holdings
Tel Aviv,
Israel
| $3K | – | – | – |
|
|
FWM
29
Focused Wealth Management
Newburgh,
New York
| $2K | +$1.75K | +6 | +300% |
|
|
LTFS
30
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
RE
32
RBC Europe
London,
United Kingdom
| $86 | – | – | – |
|
|
MC
33
Menta Capital
San Francisco,
California
| – | -$33K | -127 | Closed |
|
|
34
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$26K | -102 | Closed |
|
|
35
Renaissance Technologies
New York
| – | -$27K | -102 | Closed |
|
|
TSS
36
Two Sigma Securities
New York
| – | -$25K | -94 | Closed |
|
|
OC
37
Oppenheimer & Co
New York
| – | -$10K | -39 | Closed |
|
BLRX Hedge Fund Activity: Q1 2019 in Review
31 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BioLineRX (BLRX) for Q1 2019, worth a combined $16.3M — up 3.3% from $15.7M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BLRX and 5 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Senvest Management, adding an estimated $1.32M. The largest seller was Fosun International, cutting an estimated $304K.
- 31 institutional investors held BioLineRX (BLRX) as of Q1 2019, down from 34 in Q4 2018.
- Funds reported $16.3M of BioLineRX stock for Q1 2019, up 3.3% quarter-over-quarter.
- 5 funds opened new BioLineRX positions in Q1 2019 and 7 closed out, a net change of -2 holders.
- The largest BioLineRX buyer in Q1 2019 was Senvest Management, an estimated $1.32M added.
- The largest BioLineRX seller in Q1 2019 was Fosun International, an estimated $304K sold.
Based on aggregated 13F filings for Q1 2019.